Home  »  Business   »  Sotera Health Company (NASDAQ: SHC) 2.25% Incline ...

Sotera Health Company (NASDAQ: SHC) 2.25% Incline Turns Investors Off From Company Stock

Sotera Health Company (NASDAQ:SHC) traded at $17.30 at close of the session on Monday, 01/23/23, made an upward move of 2.25% on its previous day’s price.

Looking at the stock we see that its previous close was $16.92 with the day’s price range being $17.01 – $17.605. The company has a trailing 12-month PE ratio of 40.05. In terms of its 52-week price range, SHC has a high of $24.90 and a low of $5.78. The company’s stock has gained about 124.38% over that past 30 days.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Sotera Health Company has a market cap of $4.85 billion and is expected to release its quarterly earnings report on Feb 27, 2023 – Mar 03, 2023. Estimates by analysts give the company expected earnings per share (EPS) of $0.22, with the EPS growth for the year raised at $0.96 for 2022 and $1.09 for next year. These figures represent 9.10% and 13.50% growth in EPS for the two years respectively.

Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $248.2 million, with a low of $244.1 million and a high of $252.85 million. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2022 is expected to hit $1.01 billion, or 8.70% up from figures reported last year.

There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the SHC stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of Hold. Long term indicators on average place the stock in the category of 50% Buy.

Based on estimates by 7 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 4 have rated the Sotera Health Company (SHC) stock as a Hold, while 2 rate it as a Buy. 1 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Overweight and investors could take advantage and scoop up stock of the company.

Looking further, we note that the PEG ratio for the SHC stock currently stands at 2.22, and the current price level is 45.30% off its SMA20 and 82.49% from its 50-day simple moving average. The RSI (14) is pointing at 78.45 while the volatility over the past week is 5.34% and jumps to 6.09% over the past one month. The average price target for the stock over the next 12 months is $14.50, with the estimates having a low of $7.00 and a high of $25.00. These price ends are 59.54% and -44.51% off the current price level respectively, although investors could be excited at the prospect of a 24.86% if the SHC share price touches on the median price of $13.00.

Coming back to Sotera Health Company (NASDAQ:SHC), we note that the average 3-month trading volume was 2.97 million, while that of the preceding 10-day period stands at 7.41 million. Current shares outstanding are 280.14 million.

The insiders hold 0.40% of the company’s shares while institutions hold 88.20%. The data shows that short shares as of Oct 13, 2022, stood at 6.13 million at a short ratio of 1.71. This represents a 2.17% short interest in shares outstanding on Oct 13, 2022. Shares short fall in October from the previous month at 6.4 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 107.68% up in year-to-date price movement.

Leave a Comment

Your email address will not be published. Required fields are marked *